×ðÁúÍøÖ·µÇ½¹ÙÍø¾ÙÐÐÒ½Ò©×°±¸×¨ÀûÉêÇëÓë°¸ÀýÆÊÎö¼°Thomson_PharmaÊý¾Ý¿âʹÓÃÅàѵ

×ðÁúZ6 - ×ðÁúÍøÖ·Éϰ¶¹ÙÍø×÷Õߣº·¨ÎñÉ󼯲¿ ·ë½ð ×ðÁúZ6 - ×ðÁúÍøÖ·Éϰ¶¹ÙÍøÐû²¼Ê±¼ä£º2012-03-20 ×ðÁúZ6 - ×ðÁúÍøÖ·Éϰ¶¹ÙÍøä¯ÀÀÁ¿£º9238
3ÔÂ8¡¢9ÈÕ£¬£¬£¬£¬£¬ £¬×ðÁúÍøÖ·µÇ½¹ÙÍø·¨ÎñÉ󼯲¿ÁªºÏÈËÁ¦×ÊÔ´²¿·Ö±ðÔ¼ÇëThomson ReutersÖйúÊðÀíÉÌ´´ÌڿƼ¼ÓÐÏÞ¹«Ë¾Åàѵʦ¡¢¹ãÖÝÖÂÐÅΰʢ֪ʶ²úȨÊðÀíÓÐÏÞ¹«Ë¾Îé¼ÎÁê״ʦ¡¢×¨ÀûÊðÀíÈ˶Ô×ܳ§×¨ÀûÖÎÀí¡¢¿ÆÑÐÊÖÒÕÖ°Ô±¡¢×°±¸Ê¹ÓÃÖÎÀíÖ°Ô±µÈ¾ÙÐÐÁËÅàѵ¡£¡£¡£
Á½´ÎÅàѵ»á»®·ÖÕë¶ÔThomson PharmaÊý¾Ý¿â»ù±¾ÖªÊ¶¼°ÔËÓ㬣¬£¬£¬£¬ £¬ÆóҵרÀûÉêÇë֪ʶµÈÄÚÈݾÙÐÐÁËÏêϸ½â˵¡£¡£¡£ÓÈÆäÊÇÎé¼ÎÁê״ʦ½ÌѧÁËרÀûÔÚÆóҵı»®ÖеÄÔËÓ㬣¬£¬£¬£¬ £¬ÔõÑù·¢Ã÷ÊÖÒÕÁ¢Òìµã¡¢±íÊöÊÖÒÕÄÚÈÝ¡¢×¼±¸×¨ÀûÉêÇëǰÆÚÖÊÁϵÈ֪ʶ¡£¡£¡£Í¨¹ýÁ½´ÎÅàѵ£¬£¬£¬£¬£¬ £¬ÊµÊ±½â¾öÁ˲λáÕßÔÚ¿ÆÑкÍרÀûÐÅÏ¢¼ìË÷ÊÂÇéÖÐÓöµ½µÄÏÖʵÎÊÌ⣬£¬£¬£¬£¬ £¬Ìá¸ßÁËÔ±¹¤ÖªÊ¶²úȨµÄ֪ʶºÍÊìϤ£¬£¬£¬£¬£¬ £¬ÔöÇ¿ÁË֪ʶ²úȨµÄ´´Á¢ºÍ±£» £»£»¤Òâʶ¡£¡£¡£¶Ô×ܳ§Ïà¹ØÖ°Ô±½øÒ»²½Ìá¸ßרÀûÒâʶ£¬£¬£¬£¬£¬ £¬ÔÚÉêÇëרÀûʱÕÒ×¼ÊÖÒÕÁ¢Òìµã£¬£¬£¬£¬£¬ £¬ÓÐÓÃÌá¸ßÆóҵרÀûÉêÇëµÄÊýÄ¿ºÍÖÊÁ¿£¬£¬£¬£¬£¬ £¬Ïû³ýÆóÒµ¡°ÁãÊÊÓÃÐÂÐÍרÀû¡±Æðµ½ÁËÔö½ø×÷Óᣡ£¡£
×ðÁúÍøÖ·µÇ½¹ÙÍø×ܳ§¸±³§³¤ÖìÉÙè¯ÔÚÅàѵ»áÖÐÖ¸³ö£¬£¬£¬£¬£¬ £¬½üÄêÀ´£¬£¬£¬£¬£¬ £¬×ܳ§×¨ÀûÊÂÇ鳤×ãÉú³¤£¬£¬£¬£¬£¬ £¬·¢Ã÷רÀûÉêÇëÁ¿Óдó·ù¶ÈÌá¸ß£¬£¬£¬£¬£¬ £¬ÔÚ֪ʶ²úȨÊÂÇéÖÐÒ»Ö±»ñµÃÖØ´ó½±Ïî¡£¡£¡£ÏÂÒ»²½½«³ä·ÖÑéչרÀûµÄ×÷Ó㬣¬£¬£¬£¬ £¬Ò»Ö±ÌáÉý¹«Ë¾¿Æ¼¼Á¢ÒìÄÜÁ¦ºÍÊг¡¾ºÕùÁ¦£¬£¬£¬£¬£¬ £¬²¢Ï£Íûͨ¹ý´ËÀàÅàѵ£¬£¬£¬£¬£¬ £¬Ôö½øÊÊÓÃÐÂÐÍרÀûµÄÉêÇëÊÂÇ飬£¬£¬£¬£¬ £¬½øÒ»²½ÌáÉýרÀûµÄÖÊÁ¿Óëˮƽ¡£¡£¡£
    Ëæ×Å×ܳ§¿Æ¼¼Á¢ÒìµÄÒ»Ö±ÍÆ½ø£¬£¬£¬£¬£¬ £¬×ðÁúÍøÖ·µÇ½¹ÙÍø×ܳ§¿ÆÑÐÁ¢ÏîºÍרÀûÉêÇëÁ¿ÖðÄêÔö¶à£¬£¬£¬£¬£¬ £¬¿Æ¼¼Ñз¢Óë֪ʶ²úȨÊÂÇéÈ¡µÃ½ÏºÃЧ¹û¡£¡£¡£×ܳ§Îª¹ã¶«Ê¡ÖªÊ¶²úȨÊ÷Ä£ÆóÒµ£¬£¬£¬£¬£¬ £¬ÏÖÔÚÓµÓк£ÄÚÍâ·¢Ã÷רÀû35Ï£¬£¬£¬£¬ £¬2011Äê12ÔÂÒÀ¸½ÓÅÒìµÄ֪ʶ²úȨ´´Á¢¡¢ÖÎÀí¡¢±£» £»£»¤¡¢ÔËÓÃÒµ¼¨£¬£¬£¬£¬£¬ £¬»ñµÃÁËÊ×½ì¹ãÖÝÊб£» £»£»¤ÖªÊ¶²úȨÊг¤½±Î¨ÖðÒ»¸öÒ»µÈ½±¡£¡£¡£

×ðÁúZ6 - ×ðÁúÍøÖ·Éϰ¶¹ÙÍø
¡¾ÍøÕ¾µØÍ¼¡¿